Global Biological Vaccines Adjuvants Production, Demand and Key Producers, 2022-2028
An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities, and have been used in human vaccines for more than 90 years.
This report studies the global Biological Vaccines Adjuvants production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Biological Vaccines Adjuvants, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Biological Vaccines Adjuvants that contribute to its increasing demand across many markets.
The global Biological Vaccines Adjuvants market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Biological Vaccines Adjuvants total production and demand, 2017-2028, (K Units)
Global Biological Vaccines Adjuvants total production value, 2017-2028, (USD Million)
Global Biological Vaccines Adjuvants production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Biological Vaccines Adjuvants consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Biological Vaccines Adjuvants domestic production, consumption, key domestic manufacturers and share
Global Biological Vaccines Adjuvants production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Biological Vaccines Adjuvants production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Biological Vaccines Adjuvants production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Biological Vaccines Adjuvants market based on the following parameters – headquarters, production locations, products portfolio, Biological Vaccines Adjuvants revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Biological Vaccines Adjuvants market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Biological Vaccines Adjuvants Market, By Region:
1. How big is the global Biological Vaccines Adjuvants market?
2. What is the demand of the global Biological Vaccines Adjuvants market?
3. What is the year over year growth of the global Biological Vaccines Adjuvants market?
4. What is the production and production value of the global Biological Vaccines Adjuvants market?
5. Who are the key producers in the global Biological Vaccines Adjuvants market?
6. What are the growth factors driving the market demand?
This report studies the global Biological Vaccines Adjuvants production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Biological Vaccines Adjuvants, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Biological Vaccines Adjuvants that contribute to its increasing demand across many markets.
The global Biological Vaccines Adjuvants market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Biological Vaccines Adjuvants total production and demand, 2017-2028, (K Units)
Global Biological Vaccines Adjuvants total production value, 2017-2028, (USD Million)
Global Biological Vaccines Adjuvants production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Biological Vaccines Adjuvants consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Biological Vaccines Adjuvants domestic production, consumption, key domestic manufacturers and share
Global Biological Vaccines Adjuvants production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Biological Vaccines Adjuvants production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Biological Vaccines Adjuvants production by Application production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Biological Vaccines Adjuvants market based on the following parameters – headquarters, production locations, products portfolio, Biological Vaccines Adjuvants revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Biological Vaccines Adjuvants market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Biological Vaccines Adjuvants Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Aluminum Adjuvant
- Emulsions Adjuvant
- Others
- Human Vaccine
- Veterinary Vaccine
- GSK
- Dynavax Technologies
- Novavax
- Agenus
- Croda International
- Seppic
- OZ Biosciences
- Phibro Animal Health Corporation
- Associated British Foods
- InvivoGen
- Merck KGaA
- CSL Limited
- Vertellus
- Allergy Therapeutics
- Riboxx GmbH
- CaPtivat? Pharmaceuticals
- EuBiologics
- Pacific GeneTech
- Hawaii Biotech
- Vaxine Pty Ltd.
- Creative Diagnostics
- LiteVax BV
- Mukta Industries
- Oncovir
- TiterMax USA
1. How big is the global Biological Vaccines Adjuvants market?
2. What is the demand of the global Biological Vaccines Adjuvants market?
3. What is the year over year growth of the global Biological Vaccines Adjuvants market?
4. What is the production and production value of the global Biological Vaccines Adjuvants market?
5. Who are the key producers in the global Biological Vaccines Adjuvants market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Biological Vaccines Adjuvants Introduction
1.2 World Biological Vaccines Adjuvants Supply & Forecast
1.2.1 World Biological Vaccines Adjuvants Production Value (2017 & 2021 & 2028)
1.2.2 World Biological Vaccines Adjuvants Production (2017-2028)
1.2.3 World Biological Vaccines Adjuvants Pricing Trends (2017-2028)
1.3 World Biological Vaccines Adjuvants Production by Region
1.3.1 World Biological Vaccines Adjuvants Production Value by Region (2017-2028)
1.3.2 World Biological Vaccines Adjuvants Production by Region (2017-2028)
1.3.3 World Biological Vaccines Adjuvants Average Price by Region (2017-2028)
1.3.4 North America Biological Vaccines Adjuvants Production (2017-2028)
1.3.5 Europe Biological Vaccines Adjuvants Production (2017-2028)
1.3.6 China Biological Vaccines Adjuvants Production (2017-2028)
1.3.7 Japan Biological Vaccines Adjuvants Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Biological Vaccines Adjuvants Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Biological Vaccines Adjuvants Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Biological Vaccines Adjuvants Demand (2017-2028)
2.2 World Biological Vaccines Adjuvants Consumption by Region
2.2.1 World Biological Vaccines Adjuvants Consumption by Region (2017-2022)
2.2.2 World Biological Vaccines Adjuvants Consumption Forecast by Region (2023-2028)
2.3 United States Biological Vaccines Adjuvants Consumption (2017-2028)
2.4 China Biological Vaccines Adjuvants Consumption (2017-2028)
2.5 Europe Biological Vaccines Adjuvants Consumption (2017-2028)
2.6 Japan Biological Vaccines Adjuvants Consumption (2017-2028)
2.7 South Korea Biological Vaccines Adjuvants Consumption (2017-2028)
2.8 ASEAN Biological Vaccines Adjuvants Consumption (2017-2028)
2.9 India Biological Vaccines Adjuvants Consumption (2017-2028)
3 WORLD BIOLOGICAL VACCINES ADJUVANTS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Biological Vaccines Adjuvants Production Value by Manufacturer (2017-2022)
3.2 World Biological Vaccines Adjuvants Production by Manufacturer (2017-2022)
3.3 World Biological Vaccines Adjuvants Average Price by Manufacturer (2017-2022)
3.4 Biological Vaccines Adjuvants Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Biological Vaccines Adjuvants Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Biological Vaccines Adjuvants in 2021
3.5.3 Global Concentration Ratios (CR8) for Biological Vaccines Adjuvants in 2021
3.6 Biological Vaccines Adjuvants Market: Overall Company Footprint Analysis
3.6.1 Biological Vaccines Adjuvants Market: Region Footprint
3.6.2 Biological Vaccines Adjuvants Market: Company Product Type Footprint
3.6.3 Biological Vaccines Adjuvants Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Biological Vaccines Adjuvants Production Value Comparison
4.1.1 United States VS China: Biological Vaccines Adjuvants Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Biological Vaccines Adjuvants Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Biological Vaccines Adjuvants Production Comparison
4.2.1 United States VS China: Biological Vaccines Adjuvants Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Biological Vaccines Adjuvants Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Biological Vaccines Adjuvants Consumption Comparison
4.3.1 United States VS China: Biological Vaccines Adjuvants Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Biological Vaccines Adjuvants Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Biological Vaccines Adjuvants Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Biological Vaccines Adjuvants in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Biological Vaccines Adjuvants Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Biological Vaccines Adjuvants Production by Domestic Manufacturer, (2017-2022)
4.5 China Biological Vaccines Adjuvants Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Biological Vaccines Adjuvants in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Biological Vaccines Adjuvants Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Biological Vaccines Adjuvants Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Biological Vaccines Adjuvants Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Biological Vaccines Adjuvants in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Biological Vaccines Adjuvants Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Biological Vaccines Adjuvants Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Biological Vaccines Adjuvants Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Aluminum Adjuvant
5.2.2 Emulsions Adjuvant
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Biological Vaccines Adjuvants Production by Type (2017-2028)
5.3.2 World Biological Vaccines Adjuvants Production Value by Type (2017-2028)
5.3.3 World Biological Vaccines Adjuvants Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Biological Vaccines Adjuvants Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Human Vaccine
6.2.2 Veterinary Vaccine
6.3 Market Segment by Application
6.3.1 World Biological Vaccines Adjuvants Production by Application (2017-2028)
6.3.2 World Biological Vaccines Adjuvants Production Value by Application (2017-2028)
6.3.3 World Biological Vaccines Adjuvants Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 GSK
7.1.1 GSK Details
7.1.2 GSK Major Business
7.1.3 GSK Biological Vaccines Adjuvants Product and Services
7.1.4 GSK Biological Vaccines Adjuvants Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 GSK Recent Developments/Updates
7.1.6 GSK Competitive Strengths & Weaknesses
7.2 Dynavax Technologies
7.2.1 Dynavax Technologies Details
7.2.2 Dynavax Technologies Major Business
7.2.3 Dynavax Technologies Biological Vaccines Adjuvants Product and Services
7.2.4 Dynavax Technologies Biological Vaccines Adjuvants Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 Dynavax Technologies Recent Developments/Updates
7.2.6 Dynavax Technologies Competitive Strengths & Weaknesses
7.3 Novavax
7.3.1 Novavax Details
7.3.2 Novavax Major Business
7.3.3 Novavax Biological Vaccines Adjuvants Product and Services
7.3.4 Novavax Biological Vaccines Adjuvants Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Novavax Recent Developments/Updates
7.3.6 Novavax Competitive Strengths & Weaknesses
7.4 Agenus
7.4.1 Agenus Details
7.4.2 Agenus Major Business
7.4.3 Agenus Biological Vaccines Adjuvants Product and Services
7.4.4 Agenus Biological Vaccines Adjuvants Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Agenus Recent Developments/Updates
7.4.6 Agenus Competitive Strengths & Weaknesses
7.5 Croda International
7.5.1 Croda International Details
7.5.2 Croda International Major Business
7.5.3 Croda International Biological Vaccines Adjuvants Product and Services
7.5.4 Croda International Biological Vaccines Adjuvants Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Croda International Recent Developments/Updates
7.5.6 Croda International Competitive Strengths & Weaknesses
7.6 Seppic
7.6.1 Seppic Details
7.6.2 Seppic Major Business
7.6.3 Seppic Biological Vaccines Adjuvants Product and Services
7.6.4 Seppic Biological Vaccines Adjuvants Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Seppic Recent Developments/Updates
7.6.6 Seppic Competitive Strengths & Weaknesses
7.7 OZ Biosciences
7.7.1 OZ Biosciences Details
7.7.2 OZ Biosciences Major Business
7.7.3 OZ Biosciences Biological Vaccines Adjuvants Product and Services
7.7.4 OZ Biosciences Biological Vaccines Adjuvants Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 OZ Biosciences Recent Developments/Updates
7.7.6 OZ Biosciences Competitive Strengths & Weaknesses
7.8 Phibro Animal Health Corporation
7.8.1 Phibro Animal Health Corporation Details
7.8.2 Phibro Animal Health Corporation Major Business
7.8.3 Phibro Animal Health Corporation Biological Vaccines Adjuvants Product and Services
7.8.4 Phibro Animal Health Corporation Biological Vaccines Adjuvants Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 Phibro Animal Health Corporation Recent Developments/Updates
7.8.6 Phibro Animal Health Corporation Competitive Strengths & Weaknesses
7.9 Associated British Foods
7.9.1 Associated British Foods Details
7.9.2 Associated British Foods Major Business
7.9.3 Associated British Foods Biological Vaccines Adjuvants Product and Services
7.9.4 Associated British Foods Biological Vaccines Adjuvants Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 Associated British Foods Recent Developments/Updates
7.9.6 Associated British Foods Competitive Strengths & Weaknesses
7.10 InvivoGen
7.10.1 InvivoGen Details
7.10.2 InvivoGen Major Business
7.10.3 InvivoGen Biological Vaccines Adjuvants Product and Services
7.10.4 InvivoGen Biological Vaccines Adjuvants Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 InvivoGen Recent Developments/Updates
7.10.6 InvivoGen Competitive Strengths & Weaknesses
7.11 Merck KGaA
7.11.1 Merck KGaA Details
7.11.2 Merck KGaA Major Business
7.11.3 Merck KGaA Biological Vaccines Adjuvants Product and Services
7.11.4 Merck KGaA Biological Vaccines Adjuvants Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 Merck KGaA Recent Developments/Updates
7.11.6 Merck KGaA Competitive Strengths & Weaknesses
7.12 CSL Limited
7.12.1 CSL Limited Details
7.12.2 CSL Limited Major Business
7.12.3 CSL Limited Biological Vaccines Adjuvants Product and Services
7.12.4 CSL Limited Biological Vaccines Adjuvants Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 CSL Limited Recent Developments/Updates
7.12.6 CSL Limited Competitive Strengths & Weaknesses
7.13 Vertellus
7.13.1 Vertellus Details
7.13.2 Vertellus Major Business
7.13.3 Vertellus Biological Vaccines Adjuvants Product and Services
7.13.4 Vertellus Biological Vaccines Adjuvants Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.13.5 Vertellus Recent Developments/Updates
7.13.6 Vertellus Competitive Strengths & Weaknesses
7.14 Allergy Therapeutics
7.14.1 Allergy Therapeutics Details
7.14.2 Allergy Therapeutics Major Business
7.14.3 Allergy Therapeutics Biological Vaccines Adjuvants Product and Services
7.14.4 Allergy Therapeutics Biological Vaccines Adjuvants Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.14.5 Allergy Therapeutics Recent Developments/Updates
7.14.6 Allergy Therapeutics Competitive Strengths & Weaknesses
7.15 Riboxx GmbH
7.15.1 Riboxx GmbH Details
7.15.2 Riboxx GmbH Major Business
7.15.3 Riboxx GmbH Biological Vaccines Adjuvants Product and Services
7.15.4 Riboxx GmbH Biological Vaccines Adjuvants Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.15.5 Riboxx GmbH Recent Developments/Updates
7.15.6 Riboxx GmbH Competitive Strengths & Weaknesses
7.16 CaPtivat? Pharmaceuticals
7.16.1 CaPtivat? Pharmaceuticals Details
7.16.2 CaPtivat? Pharmaceuticals Major Business
7.16.3 CaPtivat? Pharmaceuticals Biological Vaccines Adjuvants Product and Services
7.16.4 CaPtivat? Pharmaceuticals Biological Vaccines Adjuvants Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.16.5 CaPtivat? Pharmaceuticals Recent Developments/Updates
7.16.6 CaPtivat? Pharmaceuticals Competitive Strengths & Weaknesses
7.17 EuBiologics
7.17.1 EuBiologics Details
7.17.2 EuBiologics Major Business
7.17.3 EuBiologics Biological Vaccines Adjuvants Product and Services
7.17.4 EuBiologics Biological Vaccines Adjuvants Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.17.5 EuBiologics Recent Developments/Updates
7.17.6 EuBiologics Competitive Strengths & Weaknesses
7.18 Pacific GeneTech
7.18.1 Pacific GeneTech Details
7.18.2 Pacific GeneTech Major Business
7.18.3 Pacific GeneTech Biological Vaccines Adjuvants Product and Services
7.18.4 Pacific GeneTech Biological Vaccines Adjuvants Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.18.5 Pacific GeneTech Recent Developments/Updates
7.18.6 Pacific GeneTech Competitive Strengths & Weaknesses
7.19 Hawaii Biotech
7.19.1 Hawaii Biotech Details
7.19.2 Hawaii Biotech Major Business
7.19.3 Hawaii Biotech Biological Vaccines Adjuvants Product and Services
7.19.4 Hawaii Biotech Biological Vaccines Adjuvants Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.19.5 Hawaii Biotech Recent Developments/Updates
7.19.6 Hawaii Biotech Competitive Strengths & Weaknesses
7.20 Vaxine Pty Ltd.
7.20.1 Vaxine Pty Ltd. Details
7.20.2 Vaxine Pty Ltd. Major Business
7.20.3 Vaxine Pty Ltd. Biological Vaccines Adjuvants Product and Services
7.20.4 Vaxine Pty Ltd. Biological Vaccines Adjuvants Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.20.5 Vaxine Pty Ltd. Recent Developments/Updates
7.20.6 Vaxine Pty Ltd. Competitive Strengths & Weaknesses
7.21 Creative Diagnostics
7.21.1 Creative Diagnostics Details
7.21.2 Creative Diagnostics Major Business
7.21.3 Creative Diagnostics Biological Vaccines Adjuvants Product and Services
7.21.4 Creative Diagnostics Biological Vaccines Adjuvants Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.21.5 Creative Diagnostics Recent Developments/Updates
7.21.6 Creative Diagnostics Competitive Strengths & Weaknesses
7.22 LiteVax BV
7.22.1 LiteVax BV Details
7.22.2 LiteVax BV Major Business
7.22.3 LiteVax BV Biological Vaccines Adjuvants Product and Services
7.22.4 LiteVax BV Biological Vaccines Adjuvants Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.22.5 LiteVax BV Recent Developments/Updates
7.22.6 LiteVax BV Competitive Strengths & Weaknesses
7.23 Mukta Industries
7.23.1 Mukta Industries Details
7.23.2 Mukta Industries Major Business
7.23.3 Mukta Industries Biological Vaccines Adjuvants Product and Services
7.23.4 Mukta Industries Biological Vaccines Adjuvants Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.23.5 Mukta Industries Recent Developments/Updates
7.23.6 Mukta Industries Competitive Strengths & Weaknesses
7.24 Oncovir
7.24.1 Oncovir Details
7.24.2 Oncovir Major Business
7.24.3 Oncovir Biological Vaccines Adjuvants Product and Services
7.24.4 Oncovir Biological Vaccines Adjuvants Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.24.5 Oncovir Recent Developments/Updates
7.24.6 Oncovir Competitive Strengths & Weaknesses
7.25 TiterMax USA
7.25.1 TiterMax USA Details
7.25.2 TiterMax USA Major Business
7.25.3 TiterMax USA Biological Vaccines Adjuvants Product and Services
7.25.4 TiterMax USA Biological Vaccines Adjuvants Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.25.5 TiterMax USA Recent Developments/Updates
7.25.6 TiterMax USA Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Biological Vaccines Adjuvants and Key Manufacturers
8.2 Biological Vaccines Adjuvants Manufacturing Costs
8.3 Biological Vaccines Adjuvants Production Process
8.4 Biological Vaccines Adjuvants Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Biological Vaccines Adjuvants Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Biological Vaccines Adjuvants Typical Distributors
9.3 Biological Vaccines Adjuvants Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 Biological Vaccines Adjuvants Introduction
1.2 World Biological Vaccines Adjuvants Supply & Forecast
1.2.1 World Biological Vaccines Adjuvants Production Value (2017 & 2021 & 2028)
1.2.2 World Biological Vaccines Adjuvants Production (2017-2028)
1.2.3 World Biological Vaccines Adjuvants Pricing Trends (2017-2028)
1.3 World Biological Vaccines Adjuvants Production by Region
1.3.1 World Biological Vaccines Adjuvants Production Value by Region (2017-2028)
1.3.2 World Biological Vaccines Adjuvants Production by Region (2017-2028)
1.3.3 World Biological Vaccines Adjuvants Average Price by Region (2017-2028)
1.3.4 North America Biological Vaccines Adjuvants Production (2017-2028)
1.3.5 Europe Biological Vaccines Adjuvants Production (2017-2028)
1.3.6 China Biological Vaccines Adjuvants Production (2017-2028)
1.3.7 Japan Biological Vaccines Adjuvants Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Biological Vaccines Adjuvants Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Biological Vaccines Adjuvants Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Biological Vaccines Adjuvants Demand (2017-2028)
2.2 World Biological Vaccines Adjuvants Consumption by Region
2.2.1 World Biological Vaccines Adjuvants Consumption by Region (2017-2022)
2.2.2 World Biological Vaccines Adjuvants Consumption Forecast by Region (2023-2028)
2.3 United States Biological Vaccines Adjuvants Consumption (2017-2028)
2.4 China Biological Vaccines Adjuvants Consumption (2017-2028)
2.5 Europe Biological Vaccines Adjuvants Consumption (2017-2028)
2.6 Japan Biological Vaccines Adjuvants Consumption (2017-2028)
2.7 South Korea Biological Vaccines Adjuvants Consumption (2017-2028)
2.8 ASEAN Biological Vaccines Adjuvants Consumption (2017-2028)
2.9 India Biological Vaccines Adjuvants Consumption (2017-2028)
3 WORLD BIOLOGICAL VACCINES ADJUVANTS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Biological Vaccines Adjuvants Production Value by Manufacturer (2017-2022)
3.2 World Biological Vaccines Adjuvants Production by Manufacturer (2017-2022)
3.3 World Biological Vaccines Adjuvants Average Price by Manufacturer (2017-2022)
3.4 Biological Vaccines Adjuvants Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Biological Vaccines Adjuvants Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Biological Vaccines Adjuvants in 2021
3.5.3 Global Concentration Ratios (CR8) for Biological Vaccines Adjuvants in 2021
3.6 Biological Vaccines Adjuvants Market: Overall Company Footprint Analysis
3.6.1 Biological Vaccines Adjuvants Market: Region Footprint
3.6.2 Biological Vaccines Adjuvants Market: Company Product Type Footprint
3.6.3 Biological Vaccines Adjuvants Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Biological Vaccines Adjuvants Production Value Comparison
4.1.1 United States VS China: Biological Vaccines Adjuvants Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Biological Vaccines Adjuvants Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Biological Vaccines Adjuvants Production Comparison
4.2.1 United States VS China: Biological Vaccines Adjuvants Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Biological Vaccines Adjuvants Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Biological Vaccines Adjuvants Consumption Comparison
4.3.1 United States VS China: Biological Vaccines Adjuvants Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Biological Vaccines Adjuvants Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Biological Vaccines Adjuvants Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Biological Vaccines Adjuvants in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Biological Vaccines Adjuvants Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Biological Vaccines Adjuvants Production by Domestic Manufacturer, (2017-2022)
4.5 China Biological Vaccines Adjuvants Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Biological Vaccines Adjuvants in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Biological Vaccines Adjuvants Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Biological Vaccines Adjuvants Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Biological Vaccines Adjuvants Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Biological Vaccines Adjuvants in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Biological Vaccines Adjuvants Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Biological Vaccines Adjuvants Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Biological Vaccines Adjuvants Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Aluminum Adjuvant
5.2.2 Emulsions Adjuvant
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Biological Vaccines Adjuvants Production by Type (2017-2028)
5.3.2 World Biological Vaccines Adjuvants Production Value by Type (2017-2028)
5.3.3 World Biological Vaccines Adjuvants Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Biological Vaccines Adjuvants Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
6.2.1 Human Vaccine
6.2.2 Veterinary Vaccine
6.3 Market Segment by Application
6.3.1 World Biological Vaccines Adjuvants Production by Application (2017-2028)
6.3.2 World Biological Vaccines Adjuvants Production Value by Application (2017-2028)
6.3.3 World Biological Vaccines Adjuvants Average Price by Application (2017-2028)
7 COMPANY PROFILES
7.1 GSK
7.1.1 GSK Details
7.1.2 GSK Major Business
7.1.3 GSK Biological Vaccines Adjuvants Product and Services
7.1.4 GSK Biological Vaccines Adjuvants Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 GSK Recent Developments/Updates
7.1.6 GSK Competitive Strengths & Weaknesses
7.2 Dynavax Technologies
7.2.1 Dynavax Technologies Details
7.2.2 Dynavax Technologies Major Business
7.2.3 Dynavax Technologies Biological Vaccines Adjuvants Product and Services
7.2.4 Dynavax Technologies Biological Vaccines Adjuvants Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 Dynavax Technologies Recent Developments/Updates
7.2.6 Dynavax Technologies Competitive Strengths & Weaknesses
7.3 Novavax
7.3.1 Novavax Details
7.3.2 Novavax Major Business
7.3.3 Novavax Biological Vaccines Adjuvants Product and Services
7.3.4 Novavax Biological Vaccines Adjuvants Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Novavax Recent Developments/Updates
7.3.6 Novavax Competitive Strengths & Weaknesses
7.4 Agenus
7.4.1 Agenus Details
7.4.2 Agenus Major Business
7.4.3 Agenus Biological Vaccines Adjuvants Product and Services
7.4.4 Agenus Biological Vaccines Adjuvants Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Agenus Recent Developments/Updates
7.4.6 Agenus Competitive Strengths & Weaknesses
7.5 Croda International
7.5.1 Croda International Details
7.5.2 Croda International Major Business
7.5.3 Croda International Biological Vaccines Adjuvants Product and Services
7.5.4 Croda International Biological Vaccines Adjuvants Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Croda International Recent Developments/Updates
7.5.6 Croda International Competitive Strengths & Weaknesses
7.6 Seppic
7.6.1 Seppic Details
7.6.2 Seppic Major Business
7.6.3 Seppic Biological Vaccines Adjuvants Product and Services
7.6.4 Seppic Biological Vaccines Adjuvants Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Seppic Recent Developments/Updates
7.6.6 Seppic Competitive Strengths & Weaknesses
7.7 OZ Biosciences
7.7.1 OZ Biosciences Details
7.7.2 OZ Biosciences Major Business
7.7.3 OZ Biosciences Biological Vaccines Adjuvants Product and Services
7.7.4 OZ Biosciences Biological Vaccines Adjuvants Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 OZ Biosciences Recent Developments/Updates
7.7.6 OZ Biosciences Competitive Strengths & Weaknesses
7.8 Phibro Animal Health Corporation
7.8.1 Phibro Animal Health Corporation Details
7.8.2 Phibro Animal Health Corporation Major Business
7.8.3 Phibro Animal Health Corporation Biological Vaccines Adjuvants Product and Services
7.8.4 Phibro Animal Health Corporation Biological Vaccines Adjuvants Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 Phibro Animal Health Corporation Recent Developments/Updates
7.8.6 Phibro Animal Health Corporation Competitive Strengths & Weaknesses
7.9 Associated British Foods
7.9.1 Associated British Foods Details
7.9.2 Associated British Foods Major Business
7.9.3 Associated British Foods Biological Vaccines Adjuvants Product and Services
7.9.4 Associated British Foods Biological Vaccines Adjuvants Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 Associated British Foods Recent Developments/Updates
7.9.6 Associated British Foods Competitive Strengths & Weaknesses
7.10 InvivoGen
7.10.1 InvivoGen Details
7.10.2 InvivoGen Major Business
7.10.3 InvivoGen Biological Vaccines Adjuvants Product and Services
7.10.4 InvivoGen Biological Vaccines Adjuvants Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 InvivoGen Recent Developments/Updates
7.10.6 InvivoGen Competitive Strengths & Weaknesses
7.11 Merck KGaA
7.11.1 Merck KGaA Details
7.11.2 Merck KGaA Major Business
7.11.3 Merck KGaA Biological Vaccines Adjuvants Product and Services
7.11.4 Merck KGaA Biological Vaccines Adjuvants Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 Merck KGaA Recent Developments/Updates
7.11.6 Merck KGaA Competitive Strengths & Weaknesses
7.12 CSL Limited
7.12.1 CSL Limited Details
7.12.2 CSL Limited Major Business
7.12.3 CSL Limited Biological Vaccines Adjuvants Product and Services
7.12.4 CSL Limited Biological Vaccines Adjuvants Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 CSL Limited Recent Developments/Updates
7.12.6 CSL Limited Competitive Strengths & Weaknesses
7.13 Vertellus
7.13.1 Vertellus Details
7.13.2 Vertellus Major Business
7.13.3 Vertellus Biological Vaccines Adjuvants Product and Services
7.13.4 Vertellus Biological Vaccines Adjuvants Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.13.5 Vertellus Recent Developments/Updates
7.13.6 Vertellus Competitive Strengths & Weaknesses
7.14 Allergy Therapeutics
7.14.1 Allergy Therapeutics Details
7.14.2 Allergy Therapeutics Major Business
7.14.3 Allergy Therapeutics Biological Vaccines Adjuvants Product and Services
7.14.4 Allergy Therapeutics Biological Vaccines Adjuvants Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.14.5 Allergy Therapeutics Recent Developments/Updates
7.14.6 Allergy Therapeutics Competitive Strengths & Weaknesses
7.15 Riboxx GmbH
7.15.1 Riboxx GmbH Details
7.15.2 Riboxx GmbH Major Business
7.15.3 Riboxx GmbH Biological Vaccines Adjuvants Product and Services
7.15.4 Riboxx GmbH Biological Vaccines Adjuvants Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.15.5 Riboxx GmbH Recent Developments/Updates
7.15.6 Riboxx GmbH Competitive Strengths & Weaknesses
7.16 CaPtivat? Pharmaceuticals
7.16.1 CaPtivat? Pharmaceuticals Details
7.16.2 CaPtivat? Pharmaceuticals Major Business
7.16.3 CaPtivat? Pharmaceuticals Biological Vaccines Adjuvants Product and Services
7.16.4 CaPtivat? Pharmaceuticals Biological Vaccines Adjuvants Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.16.5 CaPtivat? Pharmaceuticals Recent Developments/Updates
7.16.6 CaPtivat? Pharmaceuticals Competitive Strengths & Weaknesses
7.17 EuBiologics
7.17.1 EuBiologics Details
7.17.2 EuBiologics Major Business
7.17.3 EuBiologics Biological Vaccines Adjuvants Product and Services
7.17.4 EuBiologics Biological Vaccines Adjuvants Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.17.5 EuBiologics Recent Developments/Updates
7.17.6 EuBiologics Competitive Strengths & Weaknesses
7.18 Pacific GeneTech
7.18.1 Pacific GeneTech Details
7.18.2 Pacific GeneTech Major Business
7.18.3 Pacific GeneTech Biological Vaccines Adjuvants Product and Services
7.18.4 Pacific GeneTech Biological Vaccines Adjuvants Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.18.5 Pacific GeneTech Recent Developments/Updates
7.18.6 Pacific GeneTech Competitive Strengths & Weaknesses
7.19 Hawaii Biotech
7.19.1 Hawaii Biotech Details
7.19.2 Hawaii Biotech Major Business
7.19.3 Hawaii Biotech Biological Vaccines Adjuvants Product and Services
7.19.4 Hawaii Biotech Biological Vaccines Adjuvants Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.19.5 Hawaii Biotech Recent Developments/Updates
7.19.6 Hawaii Biotech Competitive Strengths & Weaknesses
7.20 Vaxine Pty Ltd.
7.20.1 Vaxine Pty Ltd. Details
7.20.2 Vaxine Pty Ltd. Major Business
7.20.3 Vaxine Pty Ltd. Biological Vaccines Adjuvants Product and Services
7.20.4 Vaxine Pty Ltd. Biological Vaccines Adjuvants Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.20.5 Vaxine Pty Ltd. Recent Developments/Updates
7.20.6 Vaxine Pty Ltd. Competitive Strengths & Weaknesses
7.21 Creative Diagnostics
7.21.1 Creative Diagnostics Details
7.21.2 Creative Diagnostics Major Business
7.21.3 Creative Diagnostics Biological Vaccines Adjuvants Product and Services
7.21.4 Creative Diagnostics Biological Vaccines Adjuvants Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.21.5 Creative Diagnostics Recent Developments/Updates
7.21.6 Creative Diagnostics Competitive Strengths & Weaknesses
7.22 LiteVax BV
7.22.1 LiteVax BV Details
7.22.2 LiteVax BV Major Business
7.22.3 LiteVax BV Biological Vaccines Adjuvants Product and Services
7.22.4 LiteVax BV Biological Vaccines Adjuvants Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.22.5 LiteVax BV Recent Developments/Updates
7.22.6 LiteVax BV Competitive Strengths & Weaknesses
7.23 Mukta Industries
7.23.1 Mukta Industries Details
7.23.2 Mukta Industries Major Business
7.23.3 Mukta Industries Biological Vaccines Adjuvants Product and Services
7.23.4 Mukta Industries Biological Vaccines Adjuvants Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.23.5 Mukta Industries Recent Developments/Updates
7.23.6 Mukta Industries Competitive Strengths & Weaknesses
7.24 Oncovir
7.24.1 Oncovir Details
7.24.2 Oncovir Major Business
7.24.3 Oncovir Biological Vaccines Adjuvants Product and Services
7.24.4 Oncovir Biological Vaccines Adjuvants Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.24.5 Oncovir Recent Developments/Updates
7.24.6 Oncovir Competitive Strengths & Weaknesses
7.25 TiterMax USA
7.25.1 TiterMax USA Details
7.25.2 TiterMax USA Major Business
7.25.3 TiterMax USA Biological Vaccines Adjuvants Product and Services
7.25.4 TiterMax USA Biological Vaccines Adjuvants Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.25.5 TiterMax USA Recent Developments/Updates
7.25.6 TiterMax USA Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Biological Vaccines Adjuvants and Key Manufacturers
8.2 Biological Vaccines Adjuvants Manufacturing Costs
8.3 Biological Vaccines Adjuvants Production Process
8.4 Biological Vaccines Adjuvants Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Biological Vaccines Adjuvants Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Biological Vaccines Adjuvants Typical Distributors
9.3 Biological Vaccines Adjuvants Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World Biological Vaccines Adjuvants Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Biological Vaccines Adjuvants Production Value by Region (2017-2022) & (USD Million)
Table 3. World Biological Vaccines Adjuvants Production Value by Region (2023-2028) & (USD Million)
Table 4. World Biological Vaccines Adjuvants Production Value Market Share by Region (2017-2022)
Table 5. World Biological Vaccines Adjuvants Production Value Market Share by Region (2023-2028)
Table 6. World Biological Vaccines Adjuvants Production by Region (2017-2022) & (K Units)
Table 7. World Biological Vaccines Adjuvants Production by Region (2023-2028) & (K Units)
Table 8. World Biological Vaccines Adjuvants Production Market Share by Region (2017-2022)
Table 9. World Biological Vaccines Adjuvants Production Market Share by Region (2023-2028)
Table 10. World Biological Vaccines Adjuvants Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Biological Vaccines Adjuvants Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Biological Vaccines Adjuvants Major Market Trends
Table 13. World Biological Vaccines Adjuvants Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Biological Vaccines Adjuvants Consumption by Region (2017-2022) & (K Units)
Table 15. World Biological Vaccines Adjuvants Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Biological Vaccines Adjuvants Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Biological Vaccines Adjuvants Producers in 2021
Table 18. World Biological Vaccines Adjuvants Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Biological Vaccines Adjuvants Producers in 2021
Table 20. World Biological Vaccines Adjuvants Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Biological Vaccines Adjuvants Company Evaluation Quadrant
Table 22. World Biological Vaccines Adjuvants Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Biological Vaccines Adjuvants Production Site of Key Manufacturer
Table 24. Biological Vaccines Adjuvants Market: Company Product Type Footprint
Table 25. Biological Vaccines Adjuvants Market: Company Product Application Footprint
Table 26. Biological Vaccines Adjuvants Competitive Factors
Table 27. Biological Vaccines Adjuvants New Entrant and Capacity Expansion Plans
Table 28. Biological Vaccines Adjuvants Mergers & Acquisitions Activity
Table 29. United States VS China Biological Vaccines Adjuvants Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Biological Vaccines Adjuvants Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Biological Vaccines Adjuvants Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Biological Vaccines Adjuvants in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Biological Vaccines Adjuvants Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Biological Vaccines Adjuvants Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Biological Vaccines Adjuvants Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Biological Vaccines Adjuvants Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Biological Vaccines Adjuvants in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Biological Vaccines Adjuvants Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Biological Vaccines Adjuvants Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Biological Vaccines Adjuvants Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Biological Vaccines Adjuvants Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Biological Vaccines Adjuvants in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Biological Vaccines Adjuvants Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Biological Vaccines Adjuvants Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Biological Vaccines Adjuvants Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Biological Vaccines Adjuvants Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Biological Vaccines Adjuvants Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Biological Vaccines Adjuvants Production by Type (2017-2022) & (K Units)
Table 49. World Biological Vaccines Adjuvants Production by Type (2023-2028) & (K Units)
Table 50. World Biological Vaccines Adjuvants Production Value by Type (2017-2022) & (USD Million)
Table 51. World Biological Vaccines Adjuvants Production Value by Type (2023-2028) & (USD Million)
Table 52. World Biological Vaccines Adjuvants Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Biological Vaccines Adjuvants Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Biological Vaccines Adjuvants Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Biological Vaccines Adjuvants Production by Application (2017-2022) & (K Units)
Table 56. World Biological Vaccines Adjuvants Production by Application (2023-2028) & (K Units)
Table 57. World Biological Vaccines Adjuvants Production Value by Application (2017-2022) & (USD Million)
Table 58. World Biological Vaccines Adjuvants Production Value by Application (2023-2028) & (USD Million)
Table 59. World Biological Vaccines Adjuvants Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Biological Vaccines Adjuvants Average Price by Application (2023-2028) & (US$/Unit)
Table 61. GSK Basic Information, Manufacturing Base and Competitors
Table 62. GSK Major Business
Table 63. GSK Biological Vaccines Adjuvants Product and Services
Table 64. GSK Biological Vaccines Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. GSK Recent Developments/Updates
Table 66. GSK Competitive Strengths & Weaknesses
Table 67. Dynavax Technologies Basic Information, Manufacturing Base and Competitors
Table 68. Dynavax Technologies Major Business
Table 69. Dynavax Technologies Biological Vaccines Adjuvants Product and Services
Table 70. Dynavax Technologies Biological Vaccines Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Dynavax Technologies Recent Developments/Updates
Table 72. Dynavax Technologies Competitive Strengths & Weaknesses
Table 73. Novavax Basic Information, Manufacturing Base and Competitors
Table 74. Novavax Major Business
Table 75. Novavax Biological Vaccines Adjuvants Product and Services
Table 76. Novavax Biological Vaccines Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Novavax Recent Developments/Updates
Table 78. Novavax Competitive Strengths & Weaknesses
Table 79. Agenus Basic Information, Manufacturing Base and Competitors
Table 80. Agenus Major Business
Table 81. Agenus Biological Vaccines Adjuvants Product and Services
Table 82. Agenus Biological Vaccines Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Agenus Recent Developments/Updates
Table 84. Agenus Competitive Strengths & Weaknesses
Table 85. Croda International Basic Information, Manufacturing Base and Competitors
Table 86. Croda International Major Business
Table 87. Croda International Biological Vaccines Adjuvants Product and Services
Table 88. Croda International Biological Vaccines Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Croda International Recent Developments/Updates
Table 90. Croda International Competitive Strengths & Weaknesses
Table 91. Seppic Basic Information, Manufacturing Base and Competitors
Table 92. Seppic Major Business
Table 93. Seppic Biological Vaccines Adjuvants Product and Services
Table 94. Seppic Biological Vaccines Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Seppic Recent Developments/Updates
Table 96. Seppic Competitive Strengths & Weaknesses
Table 97. OZ Biosciences Basic Information, Manufacturing Base and Competitors
Table 98. OZ Biosciences Major Business
Table 99. OZ Biosciences Biological Vaccines Adjuvants Product and Services
Table 100. OZ Biosciences Biological Vaccines Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. OZ Biosciences Recent Developments/Updates
Table 102. OZ Biosciences Competitive Strengths & Weaknesses
Table 103. Phibro Animal Health Corporation Basic Information, Manufacturing Base and Competitors
Table 104. Phibro Animal Health Corporation Major Business
Table 105. Phibro Animal Health Corporation Biological Vaccines Adjuvants Product and Services
Table 106. Phibro Animal Health Corporation Biological Vaccines Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Phibro Animal Health Corporation Recent Developments/Updates
Table 108. Phibro Animal Health Corporation Competitive Strengths & Weaknesses
Table 109. Associated British Foods Basic Information, Manufacturing Base and Competitors
Table 110. Associated British Foods Major Business
Table 111. Associated British Foods Biological Vaccines Adjuvants Product and Services
Table 112. Associated British Foods Biological Vaccines Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. Associated British Foods Recent Developments/Updates
Table 114. Associated British Foods Competitive Strengths & Weaknesses
Table 115. InvivoGen Basic Information, Manufacturing Base and Competitors
Table 116. InvivoGen Major Business
Table 117. InvivoGen Biological Vaccines Adjuvants Product and Services
Table 118. InvivoGen Biological Vaccines Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. InvivoGen Recent Developments/Updates
Table 120. InvivoGen Competitive Strengths & Weaknesses
Table 121. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 122. Merck KGaA Major Business
Table 123. Merck KGaA Biological Vaccines Adjuvants Product and Services
Table 124. Merck KGaA Biological Vaccines Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. Merck KGaA Recent Developments/Updates
Table 126. Merck KGaA Competitive Strengths & Weaknesses
Table 127. CSL Limited Basic Information, Manufacturing Base and Competitors
Table 128. CSL Limited Major Business
Table 129. CSL Limited Biological Vaccines Adjuvants Product and Services
Table 130. CSL Limited Biological Vaccines Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 131. CSL Limited Recent Developments/Updates
Table 132. CSL Limited Competitive Strengths & Weaknesses
Table 133. Vertellus Basic Information, Manufacturing Base and Competitors
Table 134. Vertellus Major Business
Table 135. Vertellus Biological Vaccines Adjuvants Product and Services
Table 136. Vertellus Biological Vaccines Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 137. Vertellus Recent Developments/Updates
Table 138. Vertellus Competitive Strengths & Weaknesses
Table 139. Allergy Therapeutics Basic Information, Manufacturing Base and Competitors
Table 140. Allergy Therapeutics Major Business
Table 141. Allergy Therapeutics Biological Vaccines Adjuvants Product and Services
Table 142. Allergy Therapeutics Biological Vaccines Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 143. Allergy Therapeutics Recent Developments/Updates
Table 144. Allergy Therapeutics Competitive Strengths & Weaknesses
Table 145. Riboxx GmbH Basic Information, Manufacturing Base and Competitors
Table 146. Riboxx GmbH Major Business
Table 147. Riboxx GmbH Biological Vaccines Adjuvants Product and Services
Table 148. Riboxx GmbH Biological Vaccines Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 149. Riboxx GmbH Recent Developments/Updates
Table 150. Riboxx GmbH Competitive Strengths & Weaknesses
Table 151. CaPtivat? Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 152. CaPtivat? Pharmaceuticals Major Business
Table 153. CaPtivat? Pharmaceuticals Biological Vaccines Adjuvants Product and Services
Table 154. CaPtivat? Pharmaceuticals Biological Vaccines Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 155. CaPtivat? Pharmaceuticals Recent Developments/Updates
Table 156. CaPtivat? Pharmaceuticals Competitive Strengths & Weaknesses
Table 157. EuBiologics Basic Information, Manufacturing Base and Competitors
Table 158. EuBiologics Major Business
Table 159. EuBiologics Biological Vaccines Adjuvants Product and Services
Table 160. EuBiologics Biological Vaccines Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 161. EuBiologics Recent Developments/Updates
Table 162. EuBiologics Competitive Strengths & Weaknesses
Table 163. Pacific GeneTech Basic Information, Manufacturing Base and Competitors
Table 164. Pacific GeneTech Major Business
Table 165. Pacific GeneTech Biological Vaccines Adjuvants Product and Services
Table 166. Pacific GeneTech Biological Vaccines Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 167. Pacific GeneTech Recent Developments/Updates
Table 168. Pacific GeneTech Competitive Strengths & Weaknesses
Table 169. Hawaii Biotech Basic Information, Manufacturing Base and Competitors
Table 170. Hawaii Biotech Major Business
Table 171. Hawaii Biotech Biological Vaccines Adjuvants Product and Services
Table 172. Hawaii Biotech Biological Vaccines Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 173. Hawaii Biotech Recent Developments/Updates
Table 174. Hawaii Biotech Competitive Strengths & Weaknesses
Table 175. Vaxine Pty Ltd. Basic Information, Manufacturing Base and Competitors
Table 176. Vaxine Pty Ltd. Major Business
Table 177. Vaxine Pty Ltd. Biological Vaccines Adjuvants Product and Services
Table 178. Vaxine Pty Ltd. Biological Vaccines Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 179. Vaxine Pty Ltd. Recent Developments/Updates
Table 180. Vaxine Pty Ltd. Competitive Strengths & Weaknesses
Table 181. Creative Diagnostics Basic Information, Manufacturing Base and Competitors
Table 182. Creative Diagnostics Major Business
Table 183. Creative Diagnostics Biological Vaccines Adjuvants Product and Services
Table 184. Creative Diagnostics Biological Vaccines Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 185. Creative Diagnostics Recent Developments/Updates
Table 186. Creative Diagnostics Competitive Strengths & Weaknesses
Table 187. LiteVax BV Basic Information, Manufacturing Base and Competitors
Table 188. LiteVax BV Major Business
Table 189. LiteVax BV Biological Vaccines Adjuvants Product and Services
Table 190. LiteVax BV Biological Vaccines Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 191. LiteVax BV Recent Developments/Updates
Table 192. LiteVax BV Competitive Strengths & Weaknesses
Table 193. Mukta Industries Basic Information, Manufacturing Base and Competitors
Table 194. Mukta Industries Major Business
Table 195. Mukta Industries Biological Vaccines Adjuvants Product and Services
Table 196. Mukta Industries Biological Vaccines Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 197. Mukta Industries Recent Developments/Updates
Table 198. Mukta Industries Competitive Strengths & Weaknesses
Table 199. Oncovir Basic Information, Manufacturing Base and Competitors
Table 200. Oncovir Major Business
Table 201. Oncovir Biological Vaccines Adjuvants Product and Services
Table 202. Oncovir Biological Vaccines Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 203. Oncovir Recent Developments/Updates
Table 204. TiterMax USA Basic Information, Manufacturing Base and Competitors
Table 205. TiterMax USA Major Business
Table 206. TiterMax USA Biological Vaccines Adjuvants Product and Services
Table 207. TiterMax USA Biological Vaccines Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 208. Biological Vaccines Adjuvants Raw Material
Table 209. Key Manufacturers of Biological Vaccines Adjuvants Raw Materials
Table 210. Biological Vaccines Adjuvants Typical Distributors
Table 211. Biological Vaccines Adjuvants Typical Customers
Table 1. World Biological Vaccines Adjuvants Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Biological Vaccines Adjuvants Production Value by Region (2017-2022) & (USD Million)
Table 3. World Biological Vaccines Adjuvants Production Value by Region (2023-2028) & (USD Million)
Table 4. World Biological Vaccines Adjuvants Production Value Market Share by Region (2017-2022)
Table 5. World Biological Vaccines Adjuvants Production Value Market Share by Region (2023-2028)
Table 6. World Biological Vaccines Adjuvants Production by Region (2017-2022) & (K Units)
Table 7. World Biological Vaccines Adjuvants Production by Region (2023-2028) & (K Units)
Table 8. World Biological Vaccines Adjuvants Production Market Share by Region (2017-2022)
Table 9. World Biological Vaccines Adjuvants Production Market Share by Region (2023-2028)
Table 10. World Biological Vaccines Adjuvants Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Biological Vaccines Adjuvants Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Biological Vaccines Adjuvants Major Market Trends
Table 13. World Biological Vaccines Adjuvants Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Biological Vaccines Adjuvants Consumption by Region (2017-2022) & (K Units)
Table 15. World Biological Vaccines Adjuvants Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Biological Vaccines Adjuvants Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Biological Vaccines Adjuvants Producers in 2021
Table 18. World Biological Vaccines Adjuvants Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Biological Vaccines Adjuvants Producers in 2021
Table 20. World Biological Vaccines Adjuvants Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Biological Vaccines Adjuvants Company Evaluation Quadrant
Table 22. World Biological Vaccines Adjuvants Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Biological Vaccines Adjuvants Production Site of Key Manufacturer
Table 24. Biological Vaccines Adjuvants Market: Company Product Type Footprint
Table 25. Biological Vaccines Adjuvants Market: Company Product Application Footprint
Table 26. Biological Vaccines Adjuvants Competitive Factors
Table 27. Biological Vaccines Adjuvants New Entrant and Capacity Expansion Plans
Table 28. Biological Vaccines Adjuvants Mergers & Acquisitions Activity
Table 29. United States VS China Biological Vaccines Adjuvants Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Biological Vaccines Adjuvants Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Biological Vaccines Adjuvants Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Biological Vaccines Adjuvants in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Biological Vaccines Adjuvants Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Biological Vaccines Adjuvants Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Biological Vaccines Adjuvants Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Biological Vaccines Adjuvants Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Biological Vaccines Adjuvants in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Biological Vaccines Adjuvants Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Biological Vaccines Adjuvants Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Biological Vaccines Adjuvants Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Biological Vaccines Adjuvants Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Biological Vaccines Adjuvants in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Biological Vaccines Adjuvants Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Biological Vaccines Adjuvants Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Biological Vaccines Adjuvants Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Biological Vaccines Adjuvants Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Biological Vaccines Adjuvants Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Biological Vaccines Adjuvants Production by Type (2017-2022) & (K Units)
Table 49. World Biological Vaccines Adjuvants Production by Type (2023-2028) & (K Units)
Table 50. World Biological Vaccines Adjuvants Production Value by Type (2017-2022) & (USD Million)
Table 51. World Biological Vaccines Adjuvants Production Value by Type (2023-2028) & (USD Million)
Table 52. World Biological Vaccines Adjuvants Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Biological Vaccines Adjuvants Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Biological Vaccines Adjuvants Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Biological Vaccines Adjuvants Production by Application (2017-2022) & (K Units)
Table 56. World Biological Vaccines Adjuvants Production by Application (2023-2028) & (K Units)
Table 57. World Biological Vaccines Adjuvants Production Value by Application (2017-2022) & (USD Million)
Table 58. World Biological Vaccines Adjuvants Production Value by Application (2023-2028) & (USD Million)
Table 59. World Biological Vaccines Adjuvants Average Price by Application (2017-2022) & (US$/Unit)
Table 60. World Biological Vaccines Adjuvants Average Price by Application (2023-2028) & (US$/Unit)
Table 61. GSK Basic Information, Manufacturing Base and Competitors
Table 62. GSK Major Business
Table 63. GSK Biological Vaccines Adjuvants Product and Services
Table 64. GSK Biological Vaccines Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. GSK Recent Developments/Updates
Table 66. GSK Competitive Strengths & Weaknesses
Table 67. Dynavax Technologies Basic Information, Manufacturing Base and Competitors
Table 68. Dynavax Technologies Major Business
Table 69. Dynavax Technologies Biological Vaccines Adjuvants Product and Services
Table 70. Dynavax Technologies Biological Vaccines Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Dynavax Technologies Recent Developments/Updates
Table 72. Dynavax Technologies Competitive Strengths & Weaknesses
Table 73. Novavax Basic Information, Manufacturing Base and Competitors
Table 74. Novavax Major Business
Table 75. Novavax Biological Vaccines Adjuvants Product and Services
Table 76. Novavax Biological Vaccines Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Novavax Recent Developments/Updates
Table 78. Novavax Competitive Strengths & Weaknesses
Table 79. Agenus Basic Information, Manufacturing Base and Competitors
Table 80. Agenus Major Business
Table 81. Agenus Biological Vaccines Adjuvants Product and Services
Table 82. Agenus Biological Vaccines Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Agenus Recent Developments/Updates
Table 84. Agenus Competitive Strengths & Weaknesses
Table 85. Croda International Basic Information, Manufacturing Base and Competitors
Table 86. Croda International Major Business
Table 87. Croda International Biological Vaccines Adjuvants Product and Services
Table 88. Croda International Biological Vaccines Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Croda International Recent Developments/Updates
Table 90. Croda International Competitive Strengths & Weaknesses
Table 91. Seppic Basic Information, Manufacturing Base and Competitors
Table 92. Seppic Major Business
Table 93. Seppic Biological Vaccines Adjuvants Product and Services
Table 94. Seppic Biological Vaccines Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Seppic Recent Developments/Updates
Table 96. Seppic Competitive Strengths & Weaknesses
Table 97. OZ Biosciences Basic Information, Manufacturing Base and Competitors
Table 98. OZ Biosciences Major Business
Table 99. OZ Biosciences Biological Vaccines Adjuvants Product and Services
Table 100. OZ Biosciences Biological Vaccines Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. OZ Biosciences Recent Developments/Updates
Table 102. OZ Biosciences Competitive Strengths & Weaknesses
Table 103. Phibro Animal Health Corporation Basic Information, Manufacturing Base and Competitors
Table 104. Phibro Animal Health Corporation Major Business
Table 105. Phibro Animal Health Corporation Biological Vaccines Adjuvants Product and Services
Table 106. Phibro Animal Health Corporation Biological Vaccines Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Phibro Animal Health Corporation Recent Developments/Updates
Table 108. Phibro Animal Health Corporation Competitive Strengths & Weaknesses
Table 109. Associated British Foods Basic Information, Manufacturing Base and Competitors
Table 110. Associated British Foods Major Business
Table 111. Associated British Foods Biological Vaccines Adjuvants Product and Services
Table 112. Associated British Foods Biological Vaccines Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. Associated British Foods Recent Developments/Updates
Table 114. Associated British Foods Competitive Strengths & Weaknesses
Table 115. InvivoGen Basic Information, Manufacturing Base and Competitors
Table 116. InvivoGen Major Business
Table 117. InvivoGen Biological Vaccines Adjuvants Product and Services
Table 118. InvivoGen Biological Vaccines Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. InvivoGen Recent Developments/Updates
Table 120. InvivoGen Competitive Strengths & Weaknesses
Table 121. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 122. Merck KGaA Major Business
Table 123. Merck KGaA Biological Vaccines Adjuvants Product and Services
Table 124. Merck KGaA Biological Vaccines Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. Merck KGaA Recent Developments/Updates
Table 126. Merck KGaA Competitive Strengths & Weaknesses
Table 127. CSL Limited Basic Information, Manufacturing Base and Competitors
Table 128. CSL Limited Major Business
Table 129. CSL Limited Biological Vaccines Adjuvants Product and Services
Table 130. CSL Limited Biological Vaccines Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 131. CSL Limited Recent Developments/Updates
Table 132. CSL Limited Competitive Strengths & Weaknesses
Table 133. Vertellus Basic Information, Manufacturing Base and Competitors
Table 134. Vertellus Major Business
Table 135. Vertellus Biological Vaccines Adjuvants Product and Services
Table 136. Vertellus Biological Vaccines Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 137. Vertellus Recent Developments/Updates
Table 138. Vertellus Competitive Strengths & Weaknesses
Table 139. Allergy Therapeutics Basic Information, Manufacturing Base and Competitors
Table 140. Allergy Therapeutics Major Business
Table 141. Allergy Therapeutics Biological Vaccines Adjuvants Product and Services
Table 142. Allergy Therapeutics Biological Vaccines Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 143. Allergy Therapeutics Recent Developments/Updates
Table 144. Allergy Therapeutics Competitive Strengths & Weaknesses
Table 145. Riboxx GmbH Basic Information, Manufacturing Base and Competitors
Table 146. Riboxx GmbH Major Business
Table 147. Riboxx GmbH Biological Vaccines Adjuvants Product and Services
Table 148. Riboxx GmbH Biological Vaccines Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 149. Riboxx GmbH Recent Developments/Updates
Table 150. Riboxx GmbH Competitive Strengths & Weaknesses
Table 151. CaPtivat? Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 152. CaPtivat? Pharmaceuticals Major Business
Table 153. CaPtivat? Pharmaceuticals Biological Vaccines Adjuvants Product and Services
Table 154. CaPtivat? Pharmaceuticals Biological Vaccines Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 155. CaPtivat? Pharmaceuticals Recent Developments/Updates
Table 156. CaPtivat? Pharmaceuticals Competitive Strengths & Weaknesses
Table 157. EuBiologics Basic Information, Manufacturing Base and Competitors
Table 158. EuBiologics Major Business
Table 159. EuBiologics Biological Vaccines Adjuvants Product and Services
Table 160. EuBiologics Biological Vaccines Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 161. EuBiologics Recent Developments/Updates
Table 162. EuBiologics Competitive Strengths & Weaknesses
Table 163. Pacific GeneTech Basic Information, Manufacturing Base and Competitors
Table 164. Pacific GeneTech Major Business
Table 165. Pacific GeneTech Biological Vaccines Adjuvants Product and Services
Table 166. Pacific GeneTech Biological Vaccines Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 167. Pacific GeneTech Recent Developments/Updates
Table 168. Pacific GeneTech Competitive Strengths & Weaknesses
Table 169. Hawaii Biotech Basic Information, Manufacturing Base and Competitors
Table 170. Hawaii Biotech Major Business
Table 171. Hawaii Biotech Biological Vaccines Adjuvants Product and Services
Table 172. Hawaii Biotech Biological Vaccines Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 173. Hawaii Biotech Recent Developments/Updates
Table 174. Hawaii Biotech Competitive Strengths & Weaknesses
Table 175. Vaxine Pty Ltd. Basic Information, Manufacturing Base and Competitors
Table 176. Vaxine Pty Ltd. Major Business
Table 177. Vaxine Pty Ltd. Biological Vaccines Adjuvants Product and Services
Table 178. Vaxine Pty Ltd. Biological Vaccines Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 179. Vaxine Pty Ltd. Recent Developments/Updates
Table 180. Vaxine Pty Ltd. Competitive Strengths & Weaknesses
Table 181. Creative Diagnostics Basic Information, Manufacturing Base and Competitors
Table 182. Creative Diagnostics Major Business
Table 183. Creative Diagnostics Biological Vaccines Adjuvants Product and Services
Table 184. Creative Diagnostics Biological Vaccines Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 185. Creative Diagnostics Recent Developments/Updates
Table 186. Creative Diagnostics Competitive Strengths & Weaknesses
Table 187. LiteVax BV Basic Information, Manufacturing Base and Competitors
Table 188. LiteVax BV Major Business
Table 189. LiteVax BV Biological Vaccines Adjuvants Product and Services
Table 190. LiteVax BV Biological Vaccines Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 191. LiteVax BV Recent Developments/Updates
Table 192. LiteVax BV Competitive Strengths & Weaknesses
Table 193. Mukta Industries Basic Information, Manufacturing Base and Competitors
Table 194. Mukta Industries Major Business
Table 195. Mukta Industries Biological Vaccines Adjuvants Product and Services
Table 196. Mukta Industries Biological Vaccines Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 197. Mukta Industries Recent Developments/Updates
Table 198. Mukta Industries Competitive Strengths & Weaknesses
Table 199. Oncovir Basic Information, Manufacturing Base and Competitors
Table 200. Oncovir Major Business
Table 201. Oncovir Biological Vaccines Adjuvants Product and Services
Table 202. Oncovir Biological Vaccines Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 203. Oncovir Recent Developments/Updates
Table 204. TiterMax USA Basic Information, Manufacturing Base and Competitors
Table 205. TiterMax USA Major Business
Table 206. TiterMax USA Biological Vaccines Adjuvants Product and Services
Table 207. TiterMax USA Biological Vaccines Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 208. Biological Vaccines Adjuvants Raw Material
Table 209. Key Manufacturers of Biological Vaccines Adjuvants Raw Materials
Table 210. Biological Vaccines Adjuvants Typical Distributors
Table 211. Biological Vaccines Adjuvants Typical Customers
LIST OF FIGURES
Figure 1. Biological Vaccines Adjuvants Picture
Figure 2. World Biological Vaccines Adjuvants Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Biological Vaccines Adjuvants Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Biological Vaccines Adjuvants Production (2017-2028) & (K Units)
Figure 5. World Biological Vaccines Adjuvants Average Price (2017-2028) & (US$/Unit)
Figure 6. World Biological Vaccines Adjuvants Production Value Market Share by Region (2017-2028)
Figure 7. World Biological Vaccines Adjuvants Production Market Share by Region (2017-2028)
Figure 8. North America Biological Vaccines Adjuvants Production (2017-2028) & (K Units)
Figure 9. Europe Biological Vaccines Adjuvants Production (2017-2028) & (K Units)
Figure 10. China Biological Vaccines Adjuvants Production (2017-2028) & (K Units)
Figure 11. Japan Biological Vaccines Adjuvants Production (2017-2028) & (K Units)
Figure 12. Biological Vaccines Adjuvants Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Biological Vaccines Adjuvants Demand (2017-2028) & (K Units)
Figure 15. World Biological Vaccines Adjuvants Consumption Market Share by Region (2017-2028)
Figure 16. United States Biological Vaccines Adjuvants Consumption (2017-2028) & (K Units)
Figure 17. China Biological Vaccines Adjuvants Consumption (2017-2028) & (K Units)
Figure 18. Europe Biological Vaccines Adjuvants Consumption (2017-2028) & (K Units)
Figure 19. Japan Biological Vaccines Adjuvants Consumption (2017-2028) & (K Units)
Figure 20. South Korea Biological Vaccines Adjuvants Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Biological Vaccines Adjuvants Consumption (2017-2028) & (K Units)
Figure 22. India Biological Vaccines Adjuvants Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Biological Vaccines Adjuvants by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Biological Vaccines Adjuvants Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Biological Vaccines Adjuvants Markets in 2021
Figure 26. United States VS China: Biological Vaccines Adjuvants Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Biological Vaccines Adjuvants Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Biological Vaccines Adjuvants Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Biological Vaccines Adjuvants in United States
Figure 30. Key Producers and Market Share of Biological Vaccines Adjuvants in China
Figure 31. Key Producers and Market Share of Biological Vaccines Adjuvants in Rest of World
Figure 32. World Biological Vaccines Adjuvants Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Biological Vaccines Adjuvants Production Value Market Share by Type in 2021
Figure 34. Aluminum Adjuvant
Figure 35. Emulsions Adjuvant
Figure 36. Others
Figure 37. World Biological Vaccines Adjuvants Production Market Share by Type (2017-2028)
Figure 38. World Biological Vaccines Adjuvants Production Value Market Share by Type (2017-2028)
Figure 39. World Biological Vaccines Adjuvants Average Price by Type (2017-2028) & (US$/Unit)
Figure 40. World Biological Vaccines Adjuvants Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 41. World Biological Vaccines Adjuvants Production Value Market Share by Application in 2021
Figure 42. Human Vaccine
Figure 43. Veterinary Vaccine
Figure 44. World Biological Vaccines Adjuvants Production Market Share by Application (2017-2028)
Figure 45. World Biological Vaccines Adjuvants Production Value Market Share by Application (2017-2028)
Figure 46. World Biological Vaccines Adjuvants Average Price by Application (2017-2028) & (US$/Unit)
Figure 47. Manufacturing Cost Structure Analysis of Biological Vaccines Adjuvants in 2021
Figure 48. Manufacturing Process Analysis of Biological Vaccines Adjuvants
Figure 49. Biological Vaccines Adjuvants Industrial Chain
Figure 50. Distribution Channel Breakdown for Biological Vaccines Adjuvants Shipments (%): 2017-2028
Figure 51. Direct Channel Pros & Cons
Figure 52. Indirect Channel Pros & Cons
Figure 53. Methodology
Figure 54. Research Process and Data Source
Figure 1. Biological Vaccines Adjuvants Picture
Figure 2. World Biological Vaccines Adjuvants Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Biological Vaccines Adjuvants Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Biological Vaccines Adjuvants Production (2017-2028) & (K Units)
Figure 5. World Biological Vaccines Adjuvants Average Price (2017-2028) & (US$/Unit)
Figure 6. World Biological Vaccines Adjuvants Production Value Market Share by Region (2017-2028)
Figure 7. World Biological Vaccines Adjuvants Production Market Share by Region (2017-2028)
Figure 8. North America Biological Vaccines Adjuvants Production (2017-2028) & (K Units)
Figure 9. Europe Biological Vaccines Adjuvants Production (2017-2028) & (K Units)
Figure 10. China Biological Vaccines Adjuvants Production (2017-2028) & (K Units)
Figure 11. Japan Biological Vaccines Adjuvants Production (2017-2028) & (K Units)
Figure 12. Biological Vaccines Adjuvants Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Biological Vaccines Adjuvants Demand (2017-2028) & (K Units)
Figure 15. World Biological Vaccines Adjuvants Consumption Market Share by Region (2017-2028)
Figure 16. United States Biological Vaccines Adjuvants Consumption (2017-2028) & (K Units)
Figure 17. China Biological Vaccines Adjuvants Consumption (2017-2028) & (K Units)
Figure 18. Europe Biological Vaccines Adjuvants Consumption (2017-2028) & (K Units)
Figure 19. Japan Biological Vaccines Adjuvants Consumption (2017-2028) & (K Units)
Figure 20. South Korea Biological Vaccines Adjuvants Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Biological Vaccines Adjuvants Consumption (2017-2028) & (K Units)
Figure 22. India Biological Vaccines Adjuvants Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Biological Vaccines Adjuvants by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Biological Vaccines Adjuvants Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Biological Vaccines Adjuvants Markets in 2021
Figure 26. United States VS China: Biological Vaccines Adjuvants Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Biological Vaccines Adjuvants Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Biological Vaccines Adjuvants Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Biological Vaccines Adjuvants in United States
Figure 30. Key Producers and Market Share of Biological Vaccines Adjuvants in China
Figure 31. Key Producers and Market Share of Biological Vaccines Adjuvants in Rest of World
Figure 32. World Biological Vaccines Adjuvants Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Biological Vaccines Adjuvants Production Value Market Share by Type in 2021
Figure 34. Aluminum Adjuvant
Figure 35. Emulsions Adjuvant
Figure 36. Others
Figure 37. World Biological Vaccines Adjuvants Production Market Share by Type (2017-2028)
Figure 38. World Biological Vaccines Adjuvants Production Value Market Share by Type (2017-2028)
Figure 39. World Biological Vaccines Adjuvants Average Price by Type (2017-2028) & (US$/Unit)
Figure 40. World Biological Vaccines Adjuvants Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 41. World Biological Vaccines Adjuvants Production Value Market Share by Application in 2021
Figure 42. Human Vaccine
Figure 43. Veterinary Vaccine
Figure 44. World Biological Vaccines Adjuvants Production Market Share by Application (2017-2028)
Figure 45. World Biological Vaccines Adjuvants Production Value Market Share by Application (2017-2028)
Figure 46. World Biological Vaccines Adjuvants Average Price by Application (2017-2028) & (US$/Unit)
Figure 47. Manufacturing Cost Structure Analysis of Biological Vaccines Adjuvants in 2021
Figure 48. Manufacturing Process Analysis of Biological Vaccines Adjuvants
Figure 49. Biological Vaccines Adjuvants Industrial Chain
Figure 50. Distribution Channel Breakdown for Biological Vaccines Adjuvants Shipments (%): 2017-2028
Figure 51. Direct Channel Pros & Cons
Figure 52. Indirect Channel Pros & Cons
Figure 53. Methodology
Figure 54. Research Process and Data Source
